000 | 01926 a2200565 4500 | ||
---|---|---|---|
005 | 20250518002906.0 | ||
264 | 0 | _c20191025 | |
008 | 201910s 0 0 eng d | ||
022 | _a1664-3224 | ||
024 | 7 |
_a10.3389/fimmu.2018.02181 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDíaz-Molina, Beatriz | |
245 | 0 | 0 |
_aEarly Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8 _h[electronic resource] |
260 |
_bFrontiers in immunology _c2018 |
||
300 |
_a2181 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAllografts _xdrug effects |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCardiomyopathy, Dilated _xsurgery |
650 | 0 | 4 |
_aEverolimus _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 |
_aHeart Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
650 | 0 | 4 |
_aMyocardium _ximmunology |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aDiaz-Bulnes, Paula | |
700 | 1 | _aCarvajal Palao, Reyes | |
700 | 1 | _aBernardo, Maria José | |
700 | 1 | _aRodriguez, Ramón M | |
700 | 1 | _aCorte-Iglesias, Viviana | |
700 | 1 | _aMoris de la Tassa, Cesar | |
700 | 1 | _aLambert, Jose Luis | |
700 | 1 | _aSuarez-Alvarez, Beatriz | |
773 | 0 |
_tFrontiers in immunology _gvol. 9 _gp. 2181 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2018.02181 _zAvailable from publisher's website |
999 |
_c28937632 _d28937632 |